tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of John Wilkin, 10 are a BUY (100%).
Analyst John Wilkin, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 60% that have a potential upside of 33.53% achieved within 95 days.
John Wilkin’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MYGN, Myriad Genetics at 02-Oct-2026.
Analyst best performing recommendations are on PSNL (PERSONALIS).
The best stock recommendation documented was for PSNL (PERSONALIS) at 8/11/2025. The price target of $7 was fulfilled within 53 days with a profit of $2.5 (55.56%) receiving and performance score of 10.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Sep-2025
$32
$5.51 (20.80%)
$25
9 days ago
(01-Oct-2026)
5/6 (83.33%)
$4.63 (16.92%)
56
Buy Since 07-Oct-2020
$34
$7.51 (28.35%)
$25
18 days ago
(22-Sep-2026)
17/22 (77.27%)
$5.94 (21.17%)
160
Buy Since 08-May-2023
$27.5
$1.01 (3.81%)
$20
2 months 6 days ago
(04-Aug-2026)
15/15 (100%)
$2.95 (12.02%)
359
Buy Since 06-Aug-2025
$28
$1.51 (5.70%)
$21
2 months 10 days ago
(30-Jul-2026)
4/4 (100%)
$3.82 (15.80%)
78
Hold Since 09-Sep-2020
$18
$-2.96 (-14.12%)
$11
4 months 28 days ago
(12-May-2026)
12/16 (75%)
$4.37 (32.06%)
517
Which stock is John Wilkin most bullish on?
What Year was the first public recommendation made by John Wilkin?
